CD47 and neoplasm: We found that although tumor sizes were variable within each group, a noteworthy reduction of the regrown tumor volume was detected in mice treated by dual blockage with ET and CD47 antibody compared to ET or anti-CD47 alone although a significant inhibitory effect on the tumor regrowth was observed by each treatment (Fig. 6c, d).